imatinib has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ray, S | 1 |
| Bender, S | 1 |
| Kang, S | 1 |
| Lin, R | 1 |
| Glicksman, MA | 1 |
| Liu, M | 1 |
1 other study available for imatinib and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.
Topics: Adenosine Triphosphate; Amino Acid Substitution; Animals; Enzyme Stability; Humans; Leucine-Rich Rep | 2014 |